Verity Asset Management Inc. raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 0.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 20,089 shares of the exchange traded fund’s stock after buying an additional 179 shares during the period. Verity Asset Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,985,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. ORG Partners LLC bought a new stake in SPDR S&P Biotech ETF in the second quarter valued at approximately $40,000. Quintet Private Bank Europe S.A. acquired a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth approximately $40,000. ORG Wealth Partners LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $44,000. Waldron Private Wealth LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth $54,000. Finally, Resources Management Corp CT ADV raised its stake in SPDR S&P Biotech ETF by 30.3% during the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after buying an additional 138 shares during the last quarter.
SPDR S&P Biotech ETF Stock Up 0.5 %
XBI stock opened at $102.99 on Friday. The company’s fifty day simple moving average is $98.90 and its 200 day simple moving average is $95.38. SPDR S&P Biotech ETF has a 12-month low of $64.99 and a 12-month high of $103.89. The firm has a market cap of $7.85 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Airline Stocks – Top Airline Stocks to Buy Now
- Take-Two Interactive’s 2024 Comeback: New Highs Expected in 2025
- What is a Special Dividend?
- How Altimmune Could Grab a Big Chunk of the GLP-1 Market
- How to Evaluate a Stock Before Buying
- Here’s Why Etsy Management Is Investing $1 Billion in Buybacks
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.